Foresite Capital | Activity | F4
Foresite Capital Activity Every public signal F4 has attached to this firm, with sources and cross-entity links.
Podcast
Jim Tananbaum appeared on 'How America Makes Medicine' podcast episode 5 discussing how VC backed America's biotech engine How Venture Capital Backed America's Biotech Engine
Added recently
Foresite Capital named to TIME's America's Top Venture Capital Firms list for 2026 America's Top Venture Capital Firms 2026
Investment
Foresite Capital participated in Thyme Care's Series E round Thyme Care
Investment
Foresite Capital participated in Khartis Therapeutics' $50M Series B funding round Khartis Therapeutics
Milestone
Parabilis Medicines, a Foresite Capital portfolio company, went public on NASDAQ Parabilis Medicines
3 investments · FEB 2026 – JUN 2026 Show all Investment
Participated as a new investor in Stepful's $55M Series C, led by Oak HC/FT, to expand its AI-powered healthcare workforce training platform. Stepful
Investment
Co-led Pinnacle Medicines' oversubscribed $89M Series B alongside LAV to advance its oral peptide therapeutics pipeline. Pinnacle Medicines
Investment
Co-led Slate Medicines' $130M Series A financing to advance anti-PACAP therapies for migraine prevention. Slate Medicines
Press
Jim Tananbaum and Michael Rome gave a wide-ranging interview to GEN Edge on Foresite's 15th anniversary, discussing the firm's approach, Foresite Labs, AI drug discovery, and the biotech market outlook On Its 15th Anniversary, Foresite Capital Looks Ahead (GEN Edge)
Milestone
Eikon Therapeutics, a Foresite Capital portfolio company, went public with a $381M IPO Eikon Therapeutics
News
Named to TIME's list of America's Top Venture Capital Firms for 2025. TIME America's Top Venture Capital Firms 2025
New Fund
Closed Fund VI, a $900M vehicle to back roughly 20 healthcare and life-science companies across all stages. Fund VI
Investment
Co-founded and backed the $1B launch of Xaira Therapeutics, an AI-driven drug discovery company, alongside ARCH Venture Partners. Xaira Therapeutics